Clinical trials for Von Willebrand disease
13 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07404644An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)Takeda · PI: Study Director
- RECRUITINGPhase 3NCT07115004Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)Vega Therapeutics, Inc
- RECRUITINGPhase 3NCT07129343A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)Takeda · PI: Study Director
- RECRUITINGPhase 3NCT06998524A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand DiseaseHoffmann-La Roche · PI: Clinical Trials
- RECRUITINGNCT06883240An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentHoffmann-La Roche · PI: Clinical Trials
- RECRUITINGPhase 3NCT05582993A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)Takeda · PI: Study Director
- RECRUITINGPhase 3NCT06205095A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWDUnity Health Toronto
- RECRUITINGPHASE1, PHASE2NCT05776069Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)Vega Therapeutics, Inc
- ACTIVE NOT RECRUITINGNCT03853486ATHN 9: Severe VWD Natural History StudyAmerican Thrombosis and Hemostasis Network · PI: Robert Sidonio, MD
- RECRUITINGNCT03773159Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow ConditionsCentre Hospitalier Universitaire Dijon
- RECRUITINGPhase 3NCT02932618A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)Baxalta now part of Shire · PI: Study Director
- RECRUITINGPhase 4NCT02472665Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand DiseaseGrifols Therapeutics LLC
- ACTIVE NOT RECRUITINGPhase 4NCT00555555Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsGrifols Biologicals, LLC · PI: Paul J Pinciaro, PhD